HomeEltrombopag OlamineEltrombopag Olamine + Ezetimibe

Does Eltrombopag Olamine Interact with Ezetimibe?

Eltrombopag Olamine and Ezetimibe have a moderate drug interaction according to U.S. FDA drug labeling data. OATP1B1 substrate; monitor for excessive exposure and consider dose reduction if appropriate. The mechanism involves oatp1b1 transporter inhibition. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Ezetimibe Class
Dietary Cholesterol Absorption Inhibitor
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Eltrombopag Olamine and Ezetimibe occurs because oatp1b1 transporter inhibition. Clinically, this means oatp1b1 substrate; monitor for excessive exposure and consider dose reduction if appropriate. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Eltrombopag Olamine and your doctor is considering prescribing Ezetimibe (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Eltrombopag Olamine(Eltrombopag)+💊 Ezetimibe(Nexlizet)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
Dietary Cholesterol Absorption Inhibitor
Source
NLP:eltrombopag olamine

What this means in plain English

OATP1B1 substrate; monitor for excessive exposure and consider dose reduction if appropriate.

About Eltrombopag Olamine and Ezetimibe

Ezetimibe is a Dietary Cholesterol Absorption Inhibitor. Ezetimibe is also sold under the brand name Nexlizet. Both medications are taken by mouth. Eltrombopag Olamine additionally carries an FDA boxed warning, the FDA's strongest safety alert.

What the FDA label says

"OATP1B1 transporter inhibition"

📖 Source: NLP:eltrombopag olamine

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Eltrombopag Olamine and Ezetimibe against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.